SP Ventures Exits Brazilian Biotech Firm Bug with Sale to Koppert (em português)

December 18, 2017
SP Ventures Bug Agentes Biológicos LAVCA

SP Ventures exited Bug Agentes Biológicos, a Brazilian biotech firm, though a sale to Dutch biochemical company Koppert Biological Systems.

(Valor Econômico) A holandesa Koppert fechou a aquisição, por meio de sua subsidiária brasileira, da Bug Agentes Biológicos, com sede em Piracicaba. Com a aquisição da empresa de controle biológico, cujo valor não foi divulgado, a Koppert afirma chegar ao primeiro lugar no ranking do setor na América Latina.

Read more at Valor Econômico.

0
Facebook Twitter Google +

Submit VC News

Have private equity or venture capital related news that you would like to share? Submit your press releases and news to news@lavca.org.

Sector Tags

agribusiness AgTech Artificial Intelligence B2B Big Data biotech Bitcoin/Blockchain Cloud Computing Consumer/Retail delivery Digital Media & Entertainment Digital Security e-commerce ecommerce EdTech Education Education/Educational Services Energy Financial Services fintech Healthcare Healthtech Hospitality Human Resources Impact Impact Investing Information Technology Infrastructure IoT IT Logistics & Distribution Marketplaces Mobile Mobile App Private Equity Real Estate Renewable Energy SaaS Social Networks Software startups Technology Telecommunications Transportation venture capital

Geography Tags

Argentina Austria Belize Bolivia Brasil Brazil Canada Canary Caribbean Central America Chile Colombia Costa Rica Dominican Republic Ecuador El Salvador Guatemala Honduras India International INTL Israel Japan Kenya LatAm Latin America Mexico Miami Nicaragua Pan-Regional Panama Paraguay Peru Portugal Puerto Rico South Korea Spain United States Uruguay USA Venezuela
LatAm Venture Bulletin

LatAm Venture Bulletin

The LatAm Venture Bulletin is a must-read roundup of startup deals and news on emerging technologies in Latin America, delivered to over 3,000+ investors, entrepreneurs, and corporates bi-weekly.
Asset Class *
 

Tweets

Keep in touch

Twitter Linkedin Youtube